This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jäger, D. Articles by Chen, Y.-T. Search for Related Content PubMed PubMed Citation Articles by Jäger, D. Articles by Chen, Y.-T.

Identification of a Tissue-specific Putative Transcription Factor in Breast Tissue by Serological Screening of a Breast Cancer Library¹

Weill Medical College of Cornell University, New York, New York 10021 [D. J., Y-T. C.]; Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, 60488 Frankfurt, Germany [J. K., E. J., A. K.]; and Ludwig Institute for Cancer Research, New York Branch, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [E. S., A. O. G., M. J. S., L. J. O., Y-T. C.]

Application of SEREX (serological analysis of recombinant tumor cDNA expression libraries) to different tumor types has led to the identification of several categories of human tumor antigens. In this study, the analysis of a breast cancer library with autologous patient serum led to the isolation of seven genes, designated NY-BR-1 through NY-BR-7. NY-BR-1, representing 6 of 14 clones isolated, showed tissue-restricted mRNA expression in breast and testis but not in 13 other normal tissues tested. Among tumor specimens, NY-BR-1 mRNA expression was found in 21 of 25 breast cancers but in only 2 of 82 nonmammary tumors. Structural analysis of NY-BR-1 cDNA and the corresponding genomic sequences in the recently released working draft of human genome indicated that NY-BR-1 is composed of 37 exons and has an open reading frame of 4.0–4.2 kb, encoding a peptide of M_r 150,000–160,000. A bipartite nuclear localization signal motif indicates a nuclear site for NY-BR-1, and the presence of a bZIP site (DNA-binding site followed by leucine zipper motif) suggests that NY-BR-1 is a transcription factor. Additional structural features include five tandem ankyrin repeats, implying a role for NY-BR-1 in protein-protein interactions. NY-BR-1 thus represents a breast tissue-specific putative transcription factor with autoimmunogenicity in breast cancer patients. In addition to NY-BR-1, a homologous gene, NY-BR-1.1, was identified in this study. NY-BR-1.1 shares 54% amino acid homology with NY-BR-1 and also shows tissue-restricted mRNA expression. However, unlike NY-BR-1, NY-BR-1.1 mRNA is expressed in brain, in addition to breast and testis. The exon structure of NY-BR-1.1 remains to be defined. Using human genome database, NY-BR-1 was localized to chromosome 10p11–p12, and NY-BR-1.1 was tentatively localized to chromosome 9.

This article has been cited by other articles:

				M. Lacroix Significance, detection and markers of disseminated breast cancer cells Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067. [Abstract] [Full Text] [PDF]

				R. B. Parmigiani, F. Bettoni, M. D. Vibranovski, M. H. Lopes, W. K. Martins, I. W. Cunha, F. A. Soares, A. J. G. Simpson, S. J. de Souza, and A. A. Camargo Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients PNAS, November 28, 2006; 103(48): 18066 - 18071. [Abstract] [Full Text] [PDF]

				W. Wang, J. Epler, L. G. Salazar, and S. R. Riddell Recognition of Breast Cancer Cells by CD8+ Cytotoxic T-Cell Clones Specific for NY-BR-1. Cancer Res., July 1, 2006; 66(13): 6826 - 6833. [Abstract] [Full Text] [PDF]

				Z. Varga, J.-P. Theurillat, V. Filonenko, B. Sasse, B. Odermatt, A. A. Jungbluth, Y.-T. Chen, L. J. Old, A. Knuth, D. Jager, et al. Preferential Nuclear and Cytoplasmic NY-BR-1 Protein Expression in Primary Breast Cancer and Lymph Node Metastases. Clin. Cancer Res., May 1, 2006; 12(9): 2745 - 2751. [Abstract] [Full Text] [PDF]

				M. Chatterjee, S. Mohapatra, A. Ionan, G. Bawa, R. Ali-Fehmi, X. Wang, J. Nowak, B. Ye, F. A. Nahhas, K. Lu, et al. Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays Cancer Res., January 15, 2006; 66(2): 1181 - 1190. [Abstract] [Full Text] [PDF]

				L. Zhong, G. E. Hidalgo, A. J. Stromberg, N. H. Khattar, J. R. Jett, and E. A. Hirschowitz Using Protein Microarray as a Diagnostic Assay for Non-Small Cell Lung Cancer Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1308 - 1314. [Abstract] [Full Text] [PDF]

				L. Radvanyi, D. Singh-Sandhu, S. Gallichan, C. Lovitt, A. Pedyczak, G. Mallo, K. Gish, K. Kwok, W. Hanna, J. Zubovits, et al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer PNAS, August 2, 2005; 102(31): 11005 - 11010. [Abstract] [Full Text] [PDF]

				F. Fernandez-Madrid, N. Tang, H. Alansari, J. L. Granda, L. Tait, K. C. Amirikia, M. Moroianu, X. Wang, and R. L. Karvonen Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer Cancer Res., August 1, 2004; 64(15): 5089 - 5096. [Abstract] [Full Text] [PDF]

				S.-Y. Lee, Y. Obata, M. Yoshida, E. Stockert, B. Williamson, A. A. Jungbluth, Y.-T. Chen, L. J. Old, and M. J. Scanlan Immunomic analysis of human sarcoma PNAS, March 4, 2003; 100(5): 2651 - 2656. [Abstract] [Full Text] [PDF]

				A. M. Krackhardt, M. Witzens, S. Harig, F. S. Hodi, A. J. Zauls, M. Chessia, P. Barrett, and J. G. Gribben Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX Blood, August 28, 2002; 100(6): 2123 - 2131. [Abstract] [Full Text] [PDF]

				B. K. Zehentner, D. C. Dillon, Y. Jiang, J. Xu, A. Bennington, D. A. Molesh, X. Zhang, S. G. Reed, D. Persing, and R. L. Houghton Application of a Multigene Reverse Transcription-PCR Assay for Detection of Mammaglobin and Complementary Transcribed Genes in Breast Cancer Lymph Nodes Clin. Chem., August 1, 2002; 48(8): 1225 - 1231. [Abstract] [Full Text] [PDF]

				M. J. Scanlan, S. Welt, C. M. Gordon, Y.-T. Chen, A. O. Gure, E. Stockert, A. A. Jungbluth, G. Ritter, D. Jager, E. Jager, et al. Cancer-related Serological Recognition of Human Colon Cancer: Identification of Potential Diagnostic and Immunotherapeutic Targets Cancer Res., July 15, 2002; 62(14): 4041 - 4047. [Abstract] [Full Text] [PDF]